+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 19Years - 99Years
All Genders
ID06187311

Study Comparing the Safety and Effectiveness of Rivaroxaban 15mg and 20mg in Adults With Non-valvular Atrial Fibrillation

Led by Korea University Anam Hospital · Updated on 2024-01-05

940

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of two different doses of Rivaroxaban 15 mg and 20 mg daily in adults with non-valvular atrial fibrillation who do not have severe kidney problems. This phase 4, randomized, open-label study aims to compare these doses to understand their impacts on preventing stroke and systemic embolism while monitoring bleeding risks. Participants with confirmed atrial fibrillation and a qualifying risk score are included to ensure appropriate study conditions. Participants will be randomly assigned to receive either 15 mg or 20 mg of Rivaroxaban once daily for 12 months. After providing consent and completing screening tests including electrocardiograms and lab tests to exclude severe organ dysfunction, eligible participants begin treatment at a baseline visit. Follow-up visits occur at 3, 6, 9, and 12 months to monitor treatment effects and collect data. During the study, participants will undergo regular tests including blood work, vital sign checks, and electrocardiograms to monitor safety and treatment adherence. The main measurement will be the rate of major bleeding events at multiple time points throughout the year. Secondary outcomes include monitoring occurrences of stroke, embolism, heart attacks, deaths, and other bleeding events. Researchers will also track any unexpected medical visits and how consistently participants take their medication.

CONDITIONS

Brief Title

Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation

Research Team

J

Jong-il Choi, MD, PHD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here